AnaptysBio Inc’s recent filing unveils that its Director EcoR1 Capital, LLC acquired Company’s shares for reported $0.84 million on Dec 30 ’24. In the deal valued at $12.92 per share,65,184 shares were bought. As a result of this transaction, EcoR1 Capital, LLC now holds 7,860,180 shares worth roughly $186.29 million.
Then, EcoR1 Capital, LLC bought 13,268 shares, generating $171,513 in total proceeds. Upon buying the shares at $12.93, the Director now owns 7,873,448 shares.
Before that, EcoR1 Capital, LLC bought 6,646 shares. AnaptysBio Inc shares valued at $86,070 were divested by the Director at a price of $12.95 per share. As a result of the transaction, EcoR1 Capital, LLC now holds 7,880,094 shares, worth roughly $186.76 million.
H.C. Wainwright upgraded its AnaptysBio Inc [ANAB] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in early February with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ANAB and has decreased its forecast on December 11, 2024 with a “Neutral” recommendation from previously “Buy” rating. BTIG Research revised its rating on December 02, 2024. It rated ANAB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ANAB
On Friday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock jump 12.11% to $23.70. Over the last five days, the stock has gained 6.61%. AnaptysBio Inc shares have risen nearly 79.00% since the year began. Nevertheless, the stocks have fallen -0.13% over the past one year. While a 52-week high of $41.31 was reached on 06/04/25, a 52-week low of $12.21 was recorded on 02/11/25. SMA at 50 days reached $20.09, while 200 days put it at $22.77.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 21.75, which if violated will result in even more drops to 19.80. On the upside, there is a resistance level at 24.83. A further resistance level may holdings at 25.96. The Relative Strength Index (RSI) on the 14-day chart is 62.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 17.37%. Stochastics %K at 52.51% indicates the stock is a holding.
The most recent change occurred on July 22, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
